Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9834608
Binding-triggered transcriptional switches and methods of use thereof
granted -
US 9834588
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted -
US 9834513
Benzylamine derivatives
granted -
US 9834587
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted -
US 9833508
Cancer therapeutics
granted -
US 9834520
Heterocyclic compound
granted -
US 9833460
Pharmaceutical formulation
granted -
US 9833479
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
granted -
US 9833471
Hypochlorous acid-based hand sanitizer
granted -
US 9833468
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
granted -
US 9833450
Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
granted -
US 9833427
Creatine ester anti-inflammatory compounds and formulations
granted -
US 9834787
Targeted integration into stem cells
granted -
US 2017340593
MEDICAMENTS FOR SLOWING PARKINSON'S DISEASE
granted -
WO 2017203057
PROTÉINES IMMUNOGÈNES ET FRAGMENTS DE CELLES-CI À PARTIR D'ACARIENS ALLERGÈNES
granted -
US 9828435
Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency
granted -
US 9827295
Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase
granted -
US 9827202
Hot-melt extrusion of modified release multi-particulates
granted -
US 9828367
Neprilysin inhibitors
granted -
US 9827255
Fumagillol derivatives
granted -
US 9828410
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 9828426
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
granted -
US 9827239
Oligomer-opioid agonist conjugates
granted -
US 9829495
Method for differentially diagnosing ACTH-dependent Cushing's syndrome
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.